Eli Lilly just unlocked a 20-million patient market.

📰 In This Issue…

The market is shifting. Over the last few weeks, primary AI and tech stocks took a much-needed, heavy hit as institutional algorithms harvested profits from an over-extended sector. But that capital isn't sitting on the sidelines—money is aggressively diversifying and rotating straight into beaten-down value plays and defensive giants.

The biggest fundamental news of the week dropped on Friday: the government officially launched the Medicare GLP-1 Bridge program. Starting July 1, Zepbound and Foundayo will be available to eligible Medicare Part D members for a flat $50 monthly copay. The market had spent six months pricing in government pushback as a major headwind for weight-loss drugs. Instead, this policy shift instantly unlocks a massive 20-million patient volume tailwind, sending mega-cap pharma surging to new All-Time Highs.

Amateur traders get chopped up trying to buy the news after the fact, or forcing long trades in a cooling tech sector. But we stick to our golden rule: The market does not reward activity. It rewards positioning.

We don't chase headlines; we let the news act as the validation for the massive, multi-month bases we have already been mapping. The healthcare leaders on today's list have spent months coiling, shaking out weak retail hands, and quietly building institutional support. Now, the fundamental news has caught up with the technical charts, and the breakout volume is pouring in.

Here are the exact setups we are positioning for today.

Best Stocks To Buy Today

$LLY ( ▲ 0.75% ) Long Term Trade

• The Company Profile: Eli Lilly is a global pharmaceutical titan and undisputed market leader in cardiometabolic health and oncology. They just scored a massive double-catalyst: positive European regulatory backing for their leukemia drug Jaypirca, and broad Medicare $50/month coverage for their blockbuster weight-loss drugs, dramatically expanding their total addressable market.

• The Macro/Monthly View: The stock has carved out a massive Base-on-Base structure on the monthly chart, forming a tight 5-month consolidation sitting directly on top of a previous 15-month base. Remember the rule: big bases lead to big moves!

• The Daily/Weekly Setup: We just witnessed a deliberate retail shakeout followed by an immediate, authoritative recovery of the key 50-Day Moving Average.

• The Trigger: The stock broke out, pulled back in an orderly fashion to test and confirm the structural breakout level, and then exploded to new All-Time Highs backed by a massive 235% Relative Volume surge. It remains one of the absolute strongest healthcare stocks on the planet, displaying extreme relative strength while the broader market was weak.

• 💡 Tip: Use $ELIL for a 2x leveraged ETF.

Get the trade alerts, education, and edge our free readers miss.

Already a paying subscriber? Sign In.

Your Premium Subscription Includes:

• • 3–10 curated stock & crypto picks each week
• • Clear Buy/Sell Rules for Maximum Profit
• • Educational breakdowns — learn while you earn
• • 70% refund if you don’t make your money back
• • Full access to our Education Hub — learn while you earn